The Ordinary’s Peptide Serums: Do They Actually Work?

In the increasingly scientific landscape of modern skincare, few ingredient classes have garnered as much focused attention from researchers and formulators as peptides. These short chains of amino acids, the fundamental building blocks of proteins, are credited with a range of targeted actions, from signaling cellular repair to directly supporting the skin’s structural matrix. Among the brands that have democratized access to these compounds, The Ordinary by DECIEM has positioned itself prominently with a dedicated line of peptide serums. For the research-oriented user, the central question remains: do these formulations leverage established biochemical principles to deliver tangible, theoretical benefits? This analysis will dissect the science behind the ordinary peptide serum offerings, examining the mechanistic roles of their constituent peptides, evaluating the extant preclinical evidence, and providing a framework for understanding their potential place in a rational skincare regimen focused on facial health and resilience.

Biochemical Foundations: Understanding Peptides in Topical Applications

To critically assess any peptide formulation, one must first understand the fundamental science of how these molecules are theorized to function when applied topically. Peptides are sequences of amino acids, shorter than full proteins, that can act as signaling molecules or structural elements. In the context of dermal research, their proposed efficacy hinges on their ability to interact with specific cellular receptors or integrate into the skin’s extracellular matrix, thereby modulating biological processes.

The Proposed Mechanisms of Action for Topical Peptides

The primary theoretical pathways through which topical peptides may influence skin biology are categorized into several key mechanisms. Signal peptides are designed to mimic fragments of endogenous proteins like collagen or elastin. When applied, they are hypothesized to bind to fibroblast receptors, tricking the cell into perceiving a breakdown of its supporting structures and triggering a compensatory synthesis of new collagen and other matrix components. This process is often referred to in research as ‘cosmeceutical signaling’.

Enzyme-inhibitor peptides, such as those targeting matrix metalloproteinases (MMPs), aim to slow the enzymatic degradation of existing collagen and elastin fibers. By providing a substrate for these destructive enzymes to bind to instead of the skin’s natural structure, they may theoretically help preserve the integrity of the dermal matrix. Carrier peptides, meanwhile, are often complexed with trace metals like copper, which are essential cofactors for numerous wound-healing and reparative enzymatic processes within the skin.

Neurotransmitter-inhibiting peptides, like acetyl hexapeptide-8 (Argireline®), propose a different mechanism. They are theorized to interfere with the vesicle machinery responsible for releasing acetylcholine at the neuromuscular junction. In preclinical models, this inhibition is suggested to reduce the intensity of muscle contractions, which may, in theory, lead to a softening of dynamic expression lines over time. It is crucial to note that these mechanisms are largely derived from in vitro studies and animal models, and their direct, quantifiable translation to intact human skin via a topical vehicle requires careful consideration of formulation science and penetration kinetics.

Deconstructing The Ordinary’s Peptide Serum Portfolio

The Ordinary offers several serums that feature peptides as primary or supporting actives. Each formulation presents a specific combination, targeting different theoretical endpoints within the broad realm of skin maintenance and resilience. A detailed examination of their constituent peptides reveals the brand’s approach to peptides skincare, blending well-researched sequences with synergistic ingredients.

“Buffet” + Copper Peptides 1%: A Multi-Targeted Approach

This serum represents one of the brand’s most comprehensive peptide offerings. It combines multiple signal and carrier peptides with a notable inclusion of copper tripeptide-1 (GHK-Cu). The ‘Buffet’ name implies a blend aimed at addressing multiple signs of aging simultaneously. Key peptides in this formulation include Matrixyl 3000 (a combination of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7), which has been studied in vitro for its potential to stimulate collagen and hyaluronic acid production. Syn®-Ake, a tripeptide that may mimic the activity of Waglerin 1 (a peptide from temple viper venom), is included for its proposed neurotransmitter-inhibiting properties.

The inclusion of copper tripeptide-1 is particularly significant from a research perspective. GHK-Cu is a naturally occurring copper complex in human plasma that declines with age. Extensive in vitro and animal model data, as summarized in reviews, suggests it plays a role in tissue remodeling, antioxidant defense, and promoting the production of key dermal components. Its function as a carrier peptide for the essential mineral copper underpins its proposed mechanism in wound healing and skin rejuvenation contexts. This serum, therefore, embodies a multi-mechanistic strategy, targeting synthesis, inhibition, and copper-dependent repair pathways.

Multi-Peptides + HA Serum: A Hyaluronic-Focused Matrix Support

Previously known as “Buffet,” this serum offers a dense peptide matrix combined with multiple forms of hyaluronic acid (HA). It contains an impressive array of peptides, including signal peptides like palmitoyl tripeptide-1, palmitoyl tetrapeptide-7, and palmitoyl tripeptide-38, as well as non-palmitoylated peptides such as acetyl hexapeptide-8 (Argireline®). The presence of various molecular weights of HA aims to provide multi-depth hydration, theoretically creating an optimal aqueous environment for peptide activity and plumping the skin.

The combination strategy here is clear: pair collagen- and elastin-signaling peptides with a peptide proposed to influence muscle contraction, all within a highly hydrating base. This approach aims to simultaneously target structural matrix support and the appearance of dynamic lines, while hydration from HA may offer an immediate, visible smoothing effect. The theoretical benefit lies in the potential for these different peptide classes to work on complementary pathways within the skin’s complex biology.

Argireline Solution 10%: A Targeted Neurotransmitter Inhibitor

This formulation takes a singular, high-concentration approach. It features a 10% concentration of acetyl hexapeptide-8, the synthetic peptide known by the trade name Argireline®. As a dedicated product, it allows for targeted application to areas of concern, typically expression lines on the forehead and around the eyes. Its proposed mechanism, as previously mentioned, is based on preclinical models of acetylcholine release inhibition at the synaptic level.

By offering this peptide in isolation at a notable concentration, the product caters to users who wish to test or focus on this specific theoretical mode of action. It avoids potential interactions with other active ingredients and allows for precise layering within a regimen. The efficacy of such a peptide serum for face application hinges entirely on the penetration and activity of this single peptide sequence, making it a clear case study for the neurotransmitter-inhibitor class.

Evaluating the Preclinical and Formulation Evidence

Moving beyond theoretical mechanisms, the practical question of efficacy depends on two critical factors: the existence of supportive preclinical data and the formulation’s ability to deliver active peptides to their intended site of action. A significant body of in vitro and animal model research exists for many of the peptides used in The Ordinary’s serums. For instance, studies on palmitoyl oligopeptides have shown stimulation of collagen and hyaluronic acid production in fibroblast cell cultures. Research on GHK-Cu is particularly robust in preclinical wound healing and tissue regeneration models.

However, a crucial caveat for any topical peptide product is skin penetration. The stratum corneum, the skin’s outermost layer, presents a formidable barrier. To enhance penetration, many effective peptides are conjugated with fatty acids like palmitic acid (becoming “palmitoyl” peptides), which increases their lipophilicity and aids in crossing the lipid-rich corneal layers. The Ordinary utilizes this technology in several of its key peptides. Furthermore, the serum vehicle itself—typically aqueous-based with penetration enhancers like propanediol—is designed to optimize delivery. Without adequate penetration, even the most biologically active peptide in a culture dish will have no theoretical effect on living skin.

The Critical Role of pH, Stability, and Synergistic Ingredients

Peptide stability is another paramount concern. These molecules can be susceptible to degradation by light, heat, and inappropriate pH. The Ordinary packages its serums in opaque or air-tight containers to mitigate light and air exposure, a critical step for maintaining integrity. The pH of the formulation must also be compatible with both peptide stability and the skin’s acid mantle. Furthermore, the inclusion of synergistic ingredients is not merely marketing. Hyaluronic acid, present in many of these serums, provides hydration that can plump the skin and improve the appearance of fine lines independently, while also potentially creating a better environment for peptide activity. The combination of peptides with different mechanisms, as seen in the “Buffet” and Multi-Peptide serums, represents a rational, multi-targeted approach based on the complex pathophysiology of skin aging.

Integration and Rational Use in a Skincare Regimen

For those considering incorporating these peptide serums into a routine, understanding their place among other actives is key. Peptides are generally considered compatible with most other skincare ingredients, including antioxidants like vitamin C and vitamin E, and moisturizers. Their gentle nature often makes them suitable for sensitive skin types that may not tolerate retinoids or high concentrations of acids. A typical application involves applying a peptide serum to clean, dry skin, allowing it to absorb fully before layering subsequent products like moisturizers or sunscreens.

It is important to manage expectations based on the scientific premise. Unlike a peptide cream that may primarily offer hydration and occlusion, a serum is designed for targeted active delivery. The theoretical effects of peptides are generally subtle and cumulative, supporting the skin’s structure and function over time rather than providing immediate, dramatic results. They are best viewed as a long-term supportive strategy, akin to nutritional supplementation for the skin. Consistency of use is paramount, as the proposed signaling mechanisms require sustained communication with dermal cells to theoretically influence protein synthesis and cellular behavior.

In the broader context of evidence-based skincare, peptides represent a compelling category of actives with strong mechanistic plausibility and supportive preclinical data. The Ordinary’s peptide serums, by offering accessible concentrations of well-researched sequences in stabilised formulations, provide a platform for individuals to explore these benefits. Their multi-peptide blends reflect a sophisticated understanding of targeting multiple aging pathways concurrently. While direct human efficacy data from independent clinical trials on these specific formulations is limited, the foundational science of their individual components is substantial. For the biohacking-savvy audience, these products represent a tool grounded in cell biology—one that aims to provide the skin with specific biochemical instructions to support its inherent resilience and architectural integrity over the long term.

References

• Ganceviciene R, et al. Skin anti-aging strategies. Dermatoendocrinol. 2012;4(3):308–319. PubMed
• Pickart L, et al. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2018;2018:1470145. PubMed
• Lupo MP, Cole AL. Cosmeceutical peptides. Dermatol Ther. 2007;20(5):343–349. PubMed
• Zhang L, Falla TJ. Cosmeceuticals and peptides. Clin Dermatol. 2009;27(5):485–494. PubMed
• Robinson LR, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005;27(3):155–160. PubMed